| Cash flows from operating activities: | |
| Net income (loss) | -100K |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |
| Depreciation | 2.4M |
| Amortization of intangible assets | 999K |
| Provision for doubtful accounts | 99K |
| Impairment of auction rate securities | |
| Stock-based compensation and charges | 2.62M |
| Earnings of unconsolidated joint venture | -602K |
| Other non-cash items | 6K |
| Changes in operating assets and liabilities: | |
| Accounts receivable | -767K |
| Other assets | -988K |
| Accounts payable and accrued expenses | -38K |
| Deferred revenue | -700K |
| Net cash provided by operating activities | |
| Cash flows from investing activities: | |
| Purchases of property and equipment | -2.87M |
| Proceeds from the sale of auction rate securities | |
| Proceeds from the sale of marketable equity securities | |
| Distribution of earnings from unconsolidated joint venture | |
| Net cash (used in) provided by investing activities | |
| Cash flows from financing activities: | |
| Proceeds from exercise of stock options | 2.26M |
| Redemption of convertible preferred stock | |
| Payment of dividend on convertible preferred stock | 0 |
| Tax payment related to net share settlements of restricted stock awards | -388K |
| Proceeds from line of credit | |
| Principal payments on line of credit | |
| Restricted cash | |
| Proceeds from loan payable | |
| Principal payments on loan payable | -19K |
| Net cash used in financing activities | |
| Change in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | 27.12M |
| Cash and cash equivalents, end of period | 30.22M |